ObsEva Expands Leadership Team and Board of Directors with Industry Veterans (ObsEva SA)
(WorldNews Switzerland)

(Source: ObsEva SA) Geneva, Switzerland, 17 January 2017 - ObsEva SA (ObsEva), a biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that impact a woman`s reproductive health and pregnancy, announced today the appointment of a new Chief Financial Officer, Timothy M. Adams. Mr. Adams will be located in the Company`s U.S. headquarters in Boston, Massachusetts, which is expected to employ finance, IR and clinical operation people and support ObsEva`s clinical-stage programs in uterine fibroids, endometriosis, Assisted Reproductive Technology and preterm labor. Mr. Adams has over 30 years of operating experience in emerging...